Literature DB >> 7619200

New epidemiological patterns of hepatitis A and B infections in Germany.

E Bölke1, B Flehmig.   

Abstract

A sero-prevalence study of antibodies against the hepatitis A and B virus is described along with the prevalence of the surface antigen of the hepatitis B virus (HBs1 Ag). Two groups are compared: the first comprising young adults born between 1961 and 1968; the second, an older population aged 50 and above. Results show that only 3.9% of the younger population were found to have antibodies against the hepatitis A virus, in sharp contrast to the older generation in whom the prevalence of antibodies was as high as 40.3%. There is a prevalence of 0.4% of HBs Ag in the younger group, while the rate in the older population is 1.5%. Only 7.1% of the younger group were found to have antibody markers for anti-HBc2 and 3.5% for anti-HBs. In the older group the respective figures are 32.5% and 15.8%.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619200

Source DB:  PubMed          Journal:  Zentralbl Hyg Umweltmed        ISSN: 0934-8859


  3 in total

1.  Virological course of hepatitis A virus as determined by real time RT-PCR: Correlation with biochemical, immunological and genotypic profiles.

Authors:  Zahid Hussain; Bhudev C Das; Syed A Husain; Sunil K Polipalli; Tanzeel Ahmed; Nargis Begum; Subhash Medhi; Alice Verghese; Mohammad Raish; Apiradee Theamboonlers; Yong Poovorawan; Premashis Kar
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  Does mutation of hepatitis A virus exist in North India?

Authors:  Zahid Hussain; Syed A Husain; Syed T Pasha; Ranjana Anand; Abdullah Chand; Sunil K Polipalli; Shabeena Rehman; Premashis Kar
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

3.  An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.

Authors:  Giuseppe La Torre; Nicola Nicolotti; Chiara de Waure; Giacomina Chiaradia; Maria Lucia Specchia; Alice Mannocci; Walter Ricciardi
Journal:  Virol J       Date:  2008-07-24       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.